creatine
A new 12-week resistance-training study shows creatine's lean-mass benefit appeared during the initial 1-week wash-in period and not further during the subsequent 12 weeks of training, but per Layne Norton this doesn't mean creatine doesn't work — it shows the effect is likely front-loaded intracellular water gain that resets a new baseline, similar to how caffeine's perceived effect fades once your baseline shifts rather than the substance ceasing to work.
The study was a 12-week resistance training program in likely-untrained men and women, preceded by a 1-week wash-in period of either placebo or creatine.
Lean body mass was measured via DEXA at baseline, after the 1-week wash-in, and after the full 12 weeks of resistance training.
Creatine increased lean mass relative to placebo by about half a kilo, but that gain occurred during the initial 1-week wash-in, not during the 12-week training block, where there was no difference between groups.
Norton states this doesn't mean creatine doesn't work, citing 'mountains of data' showing creatine increases lean mass, strength, and several performance metrics, and may have cognitive benefits.
The likely explanation is that creatine's lean-mass effect is initially driven by increased intracellular water, since creatine is an osmolyte that pulls water into muscle cells.
Norton argues intracellular water retention is the anabolic component of creatine itself, so 'special' creatine forms marketed as not causing water retention are, by his logic, also claiming to not be anabolic, and have no evidence for the no-water-retention claim.
A limitation flagged is that the study used untrained people, whose robust general response to resistance training may have washed out or masked any ongoing creatine effect during the training phase; trained individuals might show a different pattern.
Norton draws an analogy to caffeine: people report caffeine 'stopped working' when in fact their baseline arousal level shifted upward and stayed there, so they no longer perceive further relative change even though the effect persists.
He argues intracellular water still counts as lean mass and produces real muscle-cell volumization, since muscle cells are about 70% water/fluid, so more intracellular fluid means bigger cells and bigger muscles by default, even without added contractile tissue.
Creatine alone will not make someone 'look jacked' the way steroids do.
The broader point: people often assume an initial supplement or drug benefit will keep increasing linearly, when in reality it's often a one-time reestablishment of a new baseline.
Practical guidance: only use creatine monohydrate; the study used a standard dose of 5 g/day; those who get GI discomfort with monohydrate can try splitting the dose into a half-dose morning and half-dose evening.
Norton discloses a conflict of interest: his supplement line, Outwork Nutrition, sells a product called Recovery that contains creatine monohydrate, and states his 20+ years studying the literature underlie his view that creatine monohydrate is 'king.'
The baseline-reset framing reframes a whole category of 'this supplement stopped working for me' complaints (creatine, caffeine) as a perception artifact from comparing against a shifted internal baseline, not an actual loss of ongoing efficacy.
Under Norton's framework, marketing claims that a proprietary creatine form avoids water retention are self-defeating, since he presents the intracellular osmotic water-pull as inseparable from the anabolic mechanism itself — so 'no water retention' logically implies 'not anabolic.'
The null result during the 12-week training phase may reflect a ceiling/washout effect specific to untrained subjects' outsized general adaptive response to any resistance training, rather than a genuine absence of an ongoing creatine effect — a limitation that Norton suggests could reverse in already-trained populations.
Even a 'just water' lean-mass gain is presented as functionally real muscle-cell volumization (since muscle is ~70% fluid), collapsing the common folk distinction between 'real' contractile-tissue growth and water-driven size increases.
«It doesn't mean creatine doesn't work.»
— 01:21
«We have mountains of data showing that creatine increases lean mass, increases strength, and improves several performance metrics.»
— 01:23
«creatine is an osmolyte and pulls water into muscle cells.»
— 01:46
«So, if you're claiming that your creatine doesn't cause water retention, you're claiming that your creatine isn't anabolic.»
— 02:03
«No, it still works. It's just that your relative baseline has changed.»
— 03:17
«But this thing doesn't show the creatine doesn't work. It just shows that the difference that you see may just be initially, which establishes you a new baseline of lean mass and strength, and you just don't continue to see that increase.»
— 03:32
«Because muscle cells are 70% water, or 70% fluid. So, if you put more fluid in the cell, you have bigger muscle cells.»
— 04:04
«If you're going to supplement with creatine, only use creatine monohydrate.»
— 05:10
«it is very very very clear that creatine monohydrate is king, and that's why we use it in our supplement.»
— 05:55
Reception
Mixed but skeptical reception, with methodological criticism and concerns about framing generating more engagement than supportive anecdotes.
Norton's conclusion is that the study doesn't debunk creatine — it more likely shows the well-documented lean-mass benefit is front-loaded in an initial water-driven phase that resets the baseline — while he flags the untrained-only sample as a real limitation and discloses his commercial stake in a creatine-monohydrate product.

06:11